Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect

Irrespective of age, patients with aggressive Waldenstrom macroglobulinemia (WM) who have exhausted chemo-immunotherapy-based approaches may be candidates for allogeneic hematopoietic cell transplantation (HCT), a strategy that has been rarely attempted.[1][1]–[7][2] In Seattle, conditioning with